Document Detail


Fluoroquinolones in community-acquired pneumonia when tuberculosis is around: an instructive case.
MedLine Citation:
PMID:  18277123     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Fluoroquinolones are increasingly used for the treatment of community-acquired pneumonia. However, their use has been associated with a delay in the diagnosis and treatment of pulmonary tuberculosis. We describe the clinical and insightful bacteriological course of a 39-year-old patient with pulmonary tuberculosis who had presented as having community-acquired pneumonia and was treated empirically with levofloxacin. The case highlights a major problem associated with the indiscriminate use of fluoroquinolones.
Authors:
M Grupper; I Potasman
Related Documents :
18566503 - Comments on "globally maximizing, locally minimizing: unsupervised discriminant project...
18552273 - A role for the asian peritoneal dialysis community in renal replacement therapy worldwide.
10494983 - Aids-related knowledge, attitudes, and behavior: a comparison of dutch students and dro...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  The American journal of the medical sciences     Volume:  335     ISSN:  0002-9629     ISO Abbreviation:  Am. J. Med. Sci.     Publication Date:  2008 Feb 
Date Detail:
Created Date:  2008-02-15     Completed Date:  2008-04-02     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0370506     Medline TA:  Am J Med Sci     Country:  United States    
Other Details:
Languages:  eng     Pagination:  141-4     Citation Subset:  AIM; IM    
Affiliation:
Infectious Diseases Unit, Bnai Zion Medical Center, Haifa, Israel. moti.grupper@b-zion.org.il
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Anti-Bacterial Agents / therapeutic use*
Community-Acquired Infections / diagnosis,  drug therapy,  microbiology
Fluoroquinolones / therapeutic use*
Humans
Male
Mycobacterium tuberculosis / isolation & purification
Ofloxacin / therapeutic use
Pneumonia, Bacterial / diagnosis*,  drug therapy,  microbiology*
Tuberculosis, Pulmonary / diagnosis*,  microbiology*,  radiography
Chemical
Reg. No./Substance:
0/Anti-Bacterial Agents; 0/Fluoroquinolones; 82419-36-1/Ofloxacin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Let medicine lead the way beyond the registration of clinical trials: registering hypotheses.
Next Document:  Acute Charcot arthropathy successfully treated with pamidronate: long-term follow-up.